SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Jack Russell who wrote (12059)6/11/2013 10:32:57 AM
From: NTTG1 Recommendation

Recommended By
Pogeu Mahone

  Respond to of 13111
 
The others have well thought out and executed R&D programs, their statements are supported by data that is presented and discussed at National meetings, they are not afraid of peer review vetting of their stories.

By contrast, PVCT is a true 'odd duck', with a most unorthodox (and I obviously think 'flawed') approach to licensing, their only true goal....kinda fun to talk about...very simple to understand



To: Jack Russell who wrote (12059)6/11/2013 10:40:37 AM
From: Mimbari  Read Replies (2) | Respond to of 13111
 
I'm guessing he works for the competition.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News